Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Introduction Obese and type 2 diabetic (T2DM) adolescents present with reduced insulin-stimulated glucose disposal and elevated intramyocellular lipids (IMCL) indicating comparable muscular insulin resistance and increased flux of free fatty acids (FFA) as in adult patients. In humans, the causal relationships between obesity and insulin resistance were examined in detail over the last years.Methods The impact of genetic factors was analyzed in young nonobese nondiabetic first-degree relatives of T2DM (REL-DM), whereas environmental factors were tested by challenging humans without genetic T2DM risk with lipid infusions or high-fat diets.Results REL-DM exhibit defects in mitochondrial oxidation and phosphorylation. Increased FFA availability results in accumulation of intramyocellular fatty acyl-CoA (FA-CoA) inducing a series of alterations: (i) inhibition of insulin signaling, (ii) reduction of insulin-(in)dependent glucose transport/phosphorylation, (iii) decreased insulin-stimulated glycogen synthesis, (iv) impaired insulin-stimulated oxidative phosphorylation (ATP synthesis), (v) accumulation of ectopic triglycerides (IMCL), (vi) reduced expression of peroxisome proliferator activated receptor gamma (PPARgamma) coactivator-1 (PGC-1) and PGC-1-controlled genes involved in mitochondrial biogenesis and oxidative phosphorylation and possibly also (vii) initiation of inflammatory processes by activation of PKC and nuclear factor-kappaB and decreased expression of matrix metalloproteinases (MMPs).Conclusions The abnormalities could lead to a vicious cycle in which mitochondrial dysfunction, elevation of intramycellular lipids, impaired lipid oxidation and insulin resistance amplify each other. This is similar to the adaptive changes to fasting, which prevent energy loss during excessive FFA availability. The sequence of events may start with mitochondrial dysfunction in genetic insulin resistance and with increased intramyocellular lipids in environmental insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These and other studies led to the proposal that insulin resistant humans have faulty muscle mitochondria and intrinsic deficiencies in oxidative metabolism that impinge on insulin signaling by diverting fatty acids away from oxidation and toward production of diacylglycerols and other toxic lipid species (Lowell and Shulman, 2005; Roden, 2005).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Roden, 2005
In the citing paper
“suggest that this mitochondrial defect contributes to the increased intramyocellar fat content.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [16]
In the citing paper
“Recent studies have reported a mitochondrial defect in oxidative phosphorylation in skeletal muscle in variety of insulin resistant states.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [16]
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Obesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,459
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 1×
“The relative roles of lipid delivery and intramyocellular metabolism were studied in a similarly selected group of lean REL-DM featuring 60p lower insulin sensitivity and 80p higher IMCL in soleus muscle compared with their age- and body fat mass-matched control group”
BackgroundMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“The relationship between insulin resistance, intracellular lipids and mitochondrial metabolism was recently studied by combining1Hs6,62H 2 rglucose and l5nglycerol in lean insulin-resistant elderly humans”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · cited 1×
“28 and that expression of PGC-1 and PGC-1 controlled mitochondrial genes involved in electron transport, oxidative phosphorylation including ATP synthase is impaired in overt T2DM strengthens this hypothesis”
BackgroundRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709 · cited 1×
“Impaired glucose tolerance (IGT) upon oral glucose challenge is present in 20–25p of obese youngsters and defines the prediabetic state preceding overt diabetes, which occurs in ∼4p of obese adolescents”
BackgroundMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 1×
“This was followed by reductions in glucose oxidation by 40p after 2 h, insulin-stimulated glucose disposal by 46p and muscular glycogen synthesis by 50p starting at 3 h of lipidsheparin infusion”
MethodSelf-citationItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390 · cited 1×
“22 After 6 h of lipid infusion, the 43p reduction in whole body glucose disposal was accompanied by a three-fold increase in diacylglycerol (DAG), four-fold increase in protein kinase C (PKC) activity with recruitment of the β and δ isoforms of PKC to the cell membrane as well as a 70p decrease of I κ B- α , an inhibi…”
BackgroundDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · cited 1×
“17 and reduce the intramyocellular free glucose concentration suggesting that FFA primarily inhibit glucose transport”
Background
Cited by
Items 101–149 of 149
Ashtiani, A. A., Ghanjal, A., Motaqi, M., Meftahi, G. H., Hatef, B., & Niknam, H. (2016) · Asian Journal of Sports Medicine · doi:10.5812/asjsm.37008 · Cited by 10
Role of Mitochondrial Function in Insulin Resistance
Brands, M., Verhoeven, A. J., & Serlie, M. J. M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_9 · Cited by 12
Type 2 diabetes: Gaining insight into the disease process using proteomics
Maris, M., Overbergh, L., & Mathieu, C. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780093 · Cited by 9
“The disturbed fatty acid oxidation is due to a decrease in the mitochondrial oxidative capacity, resulting from genetic background, inactivity, or other mechanisms [53].”
Sathyapala, S. A., Kemp, P. R., & Polkey, M. I. (2007) · European Respiratory Journal · doi:10.1183/09031936.00068907 · Cited by 10
“Other studies have demonstrated that muscle PGC-1a concentrations are reduced in congestive cardiac failure [9] and diabetes mellitus [ 10 ].”
BackgroundBrands, M., van Raalte, D. H., Ferraz, M. J., Sauerwein, H. P., Verhoeven, A. J., Aerts, J. M. F. G., Diamant, M., & Serlie, M. J. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3266 · Cited by 8
Mehta, R., Birerdinc, A., Wang, L., Younoszai, Z., Moazzez, A. H., Elariny, H. A., Goodman, Z. D., Chandhoke, V., Baranova, A. V., & Younossi, Z. M. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-72 · Cited by 9
“A spectrum of lipotoxicity-associated changes in expression patterns has been demonstrated both in muscle and liver of obese patients [22-24] as well as in the animal models of obesity [25].”
BackgroundForce variability in the short- and long-term type 2 diabetes mellitus
Hatef, B., Ghanjal, A., Motaqi, M., & Arab, Z. (2019) · Journal of Medical Signals & Sensors · doi:10.4103/jmss.jmss_24_18 · Cited by 8
“Strength reduction has been associated with increased neuropathy and glycated hemoglobin (HbA1c) and a longer duration of diabetes.[10-17] The endurance response of diabetic muscles is different from the healthy ones.”
Mesa redonda XXV. Adiposidad abdominal como factor de riesgo para enfermedades crónicas
Aguilar-Salinas, C. A. (2007) · Salud Pública de México · Cited by 8
Diabetes mellitus in Deutschland
Icks, A., & Roden, M. (2010) · Public Health Forum · doi:10.1016/j.phf.2009.12.003 · Cited by 7
“Lange vor der Manifestation des Typ 2 Diabetes besteht eine ausgeprägte Insulinresistenz der Muskulatur (Roden, 2005) und Fettspeicherung in der Leber (Roden, 2006).”
BackgroundSelf-citationMacia, M., Pecchi, É., Desrois, M., Lan, C., Vilmen, C., Portha, B., Bernard, M., Bendahan, D., & Giannesini, B. (2018) · Biochimie · doi:10.1016/j.biochi.2018.02.014 · Cited by 7
“The development of insulin resistance in muscle is strongly associated to microvascular complication and reduced mitochondrial capacity for glucose and lipid oxidation [3-5].”
BackgroundTargeting mitochondrial biogenesis: a potential approach for preventing and controlling diabetes
Singh, R., Mohapatra, L., & Tripathi, A. S. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-021-00360-x · Cited by 8
Shangguan, R., Hu, Z., Luo, Y., Chen, M., Lai, X., Sun, J., & Chen, S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-022-08205-3 · Cited by 9
“Indeed, mitochondria is a crucial target for manipulating intramuscular triglyceride metabolism [39] because the impaired lipid oxidation caused by mitochondria dysfunction would reduce FFA consumption and promote the accumulation of intramuscular triglycerides [40, 41].”
BackgroundInsulin actions in vivo : glucose metabolism
Ferrannini, E., & DeFronzo, R. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch14 · Cited by 12
Franssen, W. M. A., Massa, G., Eijnde, B. O., Dendale, P., Hansen, D., & Verboven, K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182010578 · Cited by 7
“A reduced skeletal muscle work efficiency is hypothesized to be caused by metabolic muscle dysfunction [31] and/or a reduced mitochondrial content [32].”
BackgroundBogdanová, K., Uherková, L., Poczatková, H., Rypka, M., & Veselý, J. (2007) · Biomedical Papers · doi:10.5507/bp.2007.040 · Cited by 5
Intermuscular Adipose Tissue in CKD: A Window into Muscle Quality and Health?
Demirci, M., Dilaver, R. G., Roshanravan, B., Ikizler, T. A., & Gamboa, J. L. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000745 · Cited by 6
Mitochondrial function in skeletal muscle in type 2 diabetes.
Rabøl, R. (2011) · PubMed · Cited by 6
Zhi-ping, H. U., Ying, W. A. N. G., Mao, W., Zhang, X., Qiao, J., & Zhang, Q. (2011) · Chin J Reprod Contracep · doi:10.1016/s1001-7844(12)60008-x · Cited by 4
Of the Fit and the Fat: Mitochondrial Abnormalities and Type 2 Diabetes Mellitus
Schrauwen, P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0295 · Cited by 4
Metabolic Syndrome, Hormones, and Exercise
Δίπλα, Κ., Zafeiridis, A., & Tordjman, K. M. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-33376-8_29 · Cited by 5
Gaesser, G. A., Angadi, S. S., Sawyer, B. J., Tucker, W. J., & Jarrett, C. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00029-6 · Cited by 3
Woojung, L., Goo, Y. T., Jung, Y., Youngsic, J., Ye, R. H., Ki, S. K., Yong, K. K., Sung, H. U., & Nam, K. S. (2012) · Journal of Medicinal Plants Research · doi:10.5897/jmpr12.761 · Cited by 3
“PPARα activation led upregulation of CPT1 (carnitine palmitoyltransferase 1), MCAD (medium-chain acyl-CoA dehydrogenase), ACO2 (acyl-CoA 2), and ECH1 (enoyl-CoA hydrotase 1) gene expression involved in mitochondrial and preoxisomal fatty acid uptake and oxidation (Blaak, 2003; Reddy and Rao, 2006; Roden, 2005).”
BackgroundRole of Epigenetic Machinery and MicRNAs in Diet-Induced Hepatocarcinogenesis
Maulik, N., & Maulik, G. (2010) · CRC Press eBooks · doi:10.1201/b10449-12 · Cited by 1
Control of fatty acid metabolism by leptin in L6 rat myoblasts is regulated by hyperinsulinemia
Eguchi, M., Shrivastava, S., Lyakhovsky, N., Kim, W. I., Palanivel, R., & Sweeney, G. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347424 · Cited by 2
Glukosestoffwechsel und Tumorwachstum
Ristow, M. (2007) · Der Onkologe · doi:10.1007/s00761-007-1289-6 · Cited by 3
Brechtel, K., Machann, J., Pick, M., Schaefer, J. F., Claussen, C. D., & Schick, F. (2009) · Korean Journal of Radiology · doi:10.3348/kjr.2009.10.6.581 · Cited by 1
“, genetics and muscle fibre composition) (9) and external (training, nutrition) factors (10-12).”
BackgroundSato, S., Nakayama, S., & Shinohara, H. (2025) · Surgery Today · doi:10.1007/s00595-025-03049-3 · Cited by 1
“Another hypothesis posits that impaired mitochondrial function in skeletal muscle, commonly observed in obesity, leads to disrupted fatty acid metabolism, thereby resulting in elevated skeletal muscle fat content [29].”
Do we inherit or acquire mitochondrial dysfunction in the metabolic syndrome and Type 2 diabetes?
Maassen, J. A. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.5.599 · Cited by 1
Assessing Multiple Features of Mitochondrial Function
Phielix, E., & Roden, M. (2013) · Diabetes · doi:10.2337/db13-0303 · Cited by 1
“In turn, these can induce oxidative stress thereby causing cellular and mitochondrial damage (10,11).”
BackgroundSelf-citationBrockman, D. A. (2013) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
Woodworth‐Hobbs, M. E. (2009) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.2812 · Cited by 1
Vaquero, A. R. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-28052013-102800 · Cited by 1
van de Weijer, T. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130705tw
Circulating microRNA in Chronic Obstructive Pulmonary Disease
Donaldson, A. V. J. (2014) · Spiral (Imperial College London) · doi:10.25560/24776
Rashid, C. S. (2013) · UKnowledge (University of Kentucky)
A molecular basis for the loss of muscle oxidative phenotype: Implications for COPD
Remels, A. H. V. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20091211ar
Deciphering mitochondrial and molecular pathology in Type 2 Diabetes Mellitus
van Tienen, F. H. J. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20110204ft
Baraldi, F. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2014.tde-09012015-172710
Examination of metabolism in diabetic offspring
Russell, R. (2011) · Louisiana State University · doi:10.31390/gradschool_dissertations.1588
Szendrödi, J., & Roden, M. (2021) · De Gruyter eBooks · doi:10.1515/9783110720037-011
Self-citationZhi-ping, Z.-P., Hu, Ying, Y., Wang, Wenwei, Mao, M., Xiaowei, X., Zhang, Jie, J., Qiao, Q., et al. (2011) · 生殖与避孕:英文版
Modulation of fat oxidation: nutritional and pharmacological approach
van Can, J. G. P. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121031jc
Dietary strategies to modulate the metabolic profile and substrate partitioning
Munsters, M. J. M. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140417mm
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3280d5f7e9
Gui, W., Zhu, W. F., Zhu, Y., Shengjie, T., 郑芬萍, Yin, X., Lin, X., & Li, H. (2020) · Figshare · doi:10.6084/m9.figshare.13161423
Gui, W., Zhu, W. F., Zhu, Y., Shengjie, T., 郑芬萍, Yin, X., Lin, X., & Li, H. (2020) · Figshare · doi:10.6084/m9.figshare.13161420
Gui, W., Zhu, W. F., Zhu, Y., Shengjie, T., 郑芬萍, Yin, X., Lin, X., & Li, H. (2020) · Figshare · doi:10.6084/m9.figshare.13161426
Cardiac Mitochondrial Adaptations Induced by Elevated Lipid Exposure
Rocha, C. D. S. A. (2015) · Spectrum Research Repository (Concordia University)
Metadata
- Authors
- Roden, M.
- Affiliations
- Hanusch Hospital (AT)
- Corresponding author
- Roden, M
- ORCID
- Roden, M
- Venue
- International Journal of Obesity
- Published
- 2005-09
- Volume
- 29
- Issue
- S2
- Pages
- S111-S115
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W1999266780
- Cited by
- 149
- References
- 34
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 5 · 2022: 1 · 2021: 5 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 8 · 2015: 8 · 2014: 12 · 2013: 11 · 2012: 12
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, muscle triglycerides, intramyocellular lipid, mitochondrial dysfunction, insulin resistance, free fatty acids, fatty acyl-CoA, insulin signaling, glucose transport, glycogen synthesis, oxidative phosphorylation, PGC-1, mitochondrial biogenesis, obesity, adolescents, first-degree relatives of diabetics, high-fat diet, lipid infusion, inflammation, matrix metalloproteinases, nuclear factor-kappaB, protein kinase C
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Dietary Fats, Humans, Insulin Resistance, Lipids, Mitochondria, Muscle, Triglycerides, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.